Pharmacologic Treatment of Heroin-Dependent Patients
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Patients with heroin dependence frequently present to internists and other physicians for heroin-related medical, psychiatric, and behavioral health problems and often seek help with reducing their heroin use. Thus, physicians should be familiar with the identification and diagnosis of heroin dependence in their patients and be able to initiate treatment of heroin dependence both directly and by referral. Recent research has provided much information concerning effective pharmacologically based treatment approaches for managing opioid withdrawal and helping patients to remain abstinent Methadone maintenance and newer approaches using L-alpha acetylmethadol and buprenorphine seem to be particularly effective in promoting relapse prevention. Although these treatments are currently provided in special drug treatment settings, recent and ongoing research indicates that the physician's office may be an effective alternative site for these treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240 · cited 1×
“The original study by Dole and Nyswander that demonstrated the efficacy of methadone in decreasing heroin use was conducted with daily doses ranging from 50 to 150 mg (86).”
BackgroundJasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 2×
“Buprenorphine is a partial rather than full agonist at the m-opioid receptor and a weak antagonist at the k-receptor; thus, it may cause fewer withdrawal symptoms and have less potential for abuse, respiratory depression, and overdose (31, 116, 117).”
BackgroundClinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773 · cited 1×
“Buprenorphine is a partial rather than full agonist at the m-opioid receptor and a weak antagonist at the k-receptor; thus, it may cause fewer withdrawal symptoms and have less potential for abuse, respiratory depression, and overdose (31, 116, 117).”
BackgroundEffective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Fleming, M. F. (1997) · JAMA · doi:10.1001/jama.1997.03540370029032 · Cited by 538
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344753.x · Cited by 402 · cited 4×
“Constipation was the only significant side effect noted in a recent dose-ranging study of buprenorphine (115).”
BackgroundInfluentialA Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 1×
“Clinical trials have shown that buprenorphine and low doses of methadone (20 to 30 mg) have similar effects on retention and illicit opioid use (126, 127).”
BackgroundDOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Cherubin, C. E., & Sapira, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00009 · Cited by 238
Cited by
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Self-citationAcute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy
Alford, D. P., Compton, P., & Samet, J. H. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00010 · Cited by 468
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 419
Metadata
- Authors
- O'Connor, P. G., & Fiellin, D. A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-07-04
- Volume
- 133
- Issue
- 1
- Pages
- 40-54
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2103210787
- Cited by
- 183
- References
- 9
- FWCI
- 19.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacologic Treatment of Heroin-Dependent Patients. https://app.cochat.ai/papers/10.7326/0003-4819-133-1-200007040-00008
- The paper
- O'Connor, P. G., & Fiellin, D. A. (2000). Pharmacologic Treatment of Heroin-Dependent Patients. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-1-200007040-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.